[Edaily Starin KIM HYUNSIK Reporter] The boy group A2O Soul, produced by former singer-turned-producer Lee Soo-man, has confirmed the release date for their debut album. A2O Soul (Photo: A2O Entertainment)According to their agency, A2O Entertainment, on the 22nd, A2O Soul will release their debut mini-album “SUPERSTAR,” featuring a total of five tracks, on the 9th of next month. All tracks will be released at 6:00 p.m. on the day of the album’s release via various music streaming platforms. A2O Soul is a 15-member group consisting of Moon, Tai, Gaku, Siwon, Seoha, Sono, Lucien, Zai, Aiden, Allure, Jet, Sora, Theo, Jun, and Hanseong. The group is composed of members from various countries, including South Korea, China, Japan, and Thailand. Previously, on the 13th, they released “Superstar”—the title track of the album—as a pre-release single. Since its release, the song has achieved notable success, reaching No. 10 on YouTube’s “Trending Music” chart in South Korea and No. 2 on QQ Music’s “New Songs” chart in China. The album features “Superstar” and “Dancing in the Dark” as its double title tracks. The music production team included Yoo Young-jin, a former in-house producer at SM Entertainment; HAAN, who worked on “STAY” by The Kid LAROI and Justin Bieber; and GENT!, who has produced tracks for Drake and Doja Cat. Lee Soo-man served as the key producer, guiding the group’s musical direction. Meanwhile, A2O Light, the girl group from A2O Entertainment that debuted on the 13th, is gaining popularity as “NEON” sweeps the top spots on major music charts, including Melon.
SAMSUNG SDI CO.,LTD. has decided to sponsor the Korean delegation to the International Chemistry Olympiad (IChO). The goal is to nurture future talent in science and technology.SAMSUNG SDI CO.,LTD. si…
Kim Dong-seon, the third son of the Hanwha Group and President of Future Strategy at Hanwha Machinery & Service Holdings (#HanwhaM&S), is strengthening the company’s independent management structure b…
“We are in discussions regarding a contract to use our solution in nationwide clinical trials in Japan. If a major hospital adopts it, it could quickly spread to affiliated regional hospitals.”Kim Don…